Anastasya Isaeva

Ms. Anastasya Isaeva


Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 March 2025 in Antibodies
Verified
Journal Article
Open access
PDF file
DSDmitry Shcherbakov
Dmitry Shcherbakov
AIAnastasya Isaeva
Anastasya Isaeva
EMEgor Mustaev
Egor Mustaev
Ebola virus disease (EVD) is an acute illness with a high-case fatality rate (CFR) caused by an RNA virus belonging to the Filoviridae family. Over the past 50 years, regular EVD outbreaks have been reported. The West African EVD outbreak of 2013–2016 proved to be significantly more widespread and complex than previous ones, resulting in approximately 11,000 deaths. A coordinated international effort was required to bring the outbreak under control. One of the main challenges faced by clinicians and researchers combating EVD was the absence of vaccines and preventive treatments. Only recently have efforts led to the development of effective therapeutic options. Among these, monoclonal antibody-based drugs have emerged as the most promising agents for the urgent treatment of EVD. This article aims to review the key milestones in the development of antibody-based therapies for EVD, tracing the journey from the use of convalescent serum to the creation of effective monoclonal antibody-based drugs and their combinations.

Verified
Journal Article
Open access
PDF file
Evgeniia Andreevna KolosovaEvgeniia Andreevna Kolosova
Evgeniia Andreevna Kolosova
OSOlga Nikolaevna Shaprova
Olga Nikolaevna Shaprova
DSDaniil Vasilyevich Shanshin
Daniil Vasilyevich Shanshin
VNValentina Nesmeyanova
Valentina Nesmeyanova
IMIuliia Merkuleva
Iuliia Merkuleva
SESvetlana Elchaninova
Svetlana Elchaninova
Identification of factors behind the level and duration of persistence of the SARS-CoV-2 antibodies in the blood is assumed to set the direction for studying humoral immunity mechanisms against COVID-19, optimizing the strategy for vaccine use, antibody-based drugs, and epidemiological control of COVID-19. Objective: This study aimed to study the relationship between clinical and demographic characteristics and the level of IgG antibodies to the RBD of SARS-CoV-2 spike protein after COVID-19 in the long term. Residents of the Altai Region of Western Siberia of Russia, Caucasians, aged from 27 to 93 years (median 53.0 years), who recovered from COVID-19 between May 2020 and February 2021 (n = 44) took part in this prospective observational study. The titer of IgG antibodies to the RBD of SARS-CoV-2 spike protein was measured repeatedly in the blood at 4–13 months from the beginning of the clinical manifestation of COVID-19 via the method of enzyme-linked immunosorbent assay. The antibody titer positively correlated with age (p = 0.013) and COVID-19 pneumonia (p = 0.002) at 20–40 and 20–24 weeks from the onset of COVID-19 symptoms, respectively. Age was positively associated with antibody titer regardless of history of COVID-19 pneumonia (beta regression coefficient p = 0.009). The antibody titer decreased in 15 (34.1%) patients, increased in 10 (22.7%) patients, and did not change in 19 (43.2%) patients from the baseline to 48–49 weeks from the onset of COVID-19 symptoms, with seropositivity persisting in all patients. Age and COVID-19 pneumonia are possibly associated with higher IgG antibodies to the spike protein RBD of SARS-CoV-2 following COVID-19 in the long term. Divergent trends of anti-RBD IgG levels in adults illustrate inter-individual differences at 4–13 months from the onset of COVID-19 symptoms.

13 February 2023 in Chemosensors
Verified
Journal Article
Open access
PDF file
EMEkaterina Mordvinova
Ekaterina Mordvinova
PNPolina A. Nikitina
Polina A. Nikitina
Olga I. YarovayaOlga I. Yarovaya
Olga I. Yarovaya
EVEkaterina A. Volosnikova
Ekaterina A. Volosnikova
DMDenis Murashkin
Denis Murashkin
DSDmitry Shcherbakov
Dmitry Shcherbakov
Angiotensin-converting enzyme 2 (ACE2), the functional receptor of SARS-CoV-2, plays a crucial role in the pathogenesis of COVID-19. ACE2 targeting holds the promise for preventing and inhibiting SARS-CoV-2 infection. In this work, we describe the development and use of a test system based on competitive ELISA for the primary screening of potential antiviral compounds. We studied the activity of the library of dyes of different groups. Several dyes (ortho-cresolphthalein, eosin (free acid), eosin (Na salt)) that inhibited the interaction of ACE2 with the spike proteins of SARS-CoV-2 have been identified among the candidates. A potential antiviral drug, methylene blue, did not show activity in our study. We believe that our results can help in the further search for inhibitors of interaction between the coronavirus spike protein and ACE2 receptor.

1 January 2022 in Физика и техника полупроводников
Verified
Journal Article
Closed access
ВСВ.п. Смагин
В.п. Смагин
AIAnastasya Isaeva
Anastasya Isaeva
ЕШЕ.а. Шелепова
Е.а. Шелепова
Nanoscale particles ZnS:Nd3+, CdS:Nd3+ and (Zn,Cd)S:Nd3+ were synthesized and doped in a polymerizing methyl methacrylate medium during the production of optically transparent polyacrylate composites of the composition PMMA/ZnS:Nd3+, PMMA/CdS:Nd3+ and PMMA/(Zn,Cd)S:Nd3+. The excitation of photoluminescence (FL) and FL of semiconductor structures in composites is associated with the transition of electrons from the valence band to the conduction band and to the levels of structural defects of semiconductor particles, followed by recombination at these levels. Based on changes in the excitation spectra of FL and FL composites, assumptions are made about the structure of particles, the distribution of Nd3+ ions in it and their effect on photoluminescence.

1 January 2020 in Журнал технической физики
Verified
Journal Article
Closed access
AIAnastasya Isaeva
Anastasya Isaeva
ВСВ.п. Смагин
В.п. Смагин
Photoluminescence of nanoscale structures based on zinc, cadmium and manganese sulfides depending on the conditions of synthesis and doping in the medium (poly)methylmethacrylate (PMMA). Photoluminescence excitation is associated with interband transitions of electrons in the semiconductor structures, absorption of optical radiation energy by defects in the crystal structure, as well as with the transfer of energy to the excited energy levels of Mn2+ ions. Luminescence occurs as a result of recombination processes at the levels of defects in the structure of the surface of particles and 4T1 → 6A1 transitions between the proper energy levels of Mn2+ ions. Based on changes in the photoluminescence spectra and photoluminescence excitation of PMMA/(Zn,Cd,Mn)S compositions, assumptions are made about the structure of particles. It is shown that their photoluminescence is affected by the distribution of Mn2+ ions in the structure of layers and on the surface of particles.

1 January 2020 in Журнал технической физики
Verified
Journal Article
Closed access
ВСВ.п. Смагин
В.п. Смагин
AIAnastasya Isaeva
Anastasya Isaeva
НЕН.с. Еремина
Н.с. Еремина
Zinc sulfide is one of the most popular luminescent semiconductors of group A(II)B(VI). Doping ZnS quantum dots with Ln3+ ions makes it possible to form nanoscale structures in a semiconductor matrix containing isolated centers of narrow-band luminescence. The introduction of quantum dots into the acrylate matrix further stabilizes the particles and allows them to form their morphology. Nanoscale structures of Zn1-x-yCuxEuyS/EuL3, where L − trifluoroacetate are anions, were synthesized by the method of emerging reagents in situ in the medium of methyl methacrylate (MMA). ZnS doping was performed by simultaneous introduction of soluble precursors of zinc sulfide, as well as copper and europium trifluoroacetates into the acrylate reaction mixture. Polymer optically transparent compositions of PMMA/Zn1-x-yCuxEuyS/EuL3 were obtained by radical polymerization of MMA in the block. The excitation of luminescence of compositions is associated with Interzone electron transitions in ZnS, with a system of levels that form alloying ions in the forbidden zone of ZnS, as well as with their own energy absorption by Eu3+ ions. Broadband luminescence of compositions is caused by intracrystalline defects formed in ZnS during doping. Narrow-band luminescence occurs as a result OF 5D0→7Fj electronic transitions in Eu3+ ions associated with quantum dots, as well as being in the polymer matrix independently of them. The transfer of energy from the donor levels of the semiconductor matrix to the levels of Eu3+ ions, followed by its release in the form of luminescence, was confirmed by the imposition of absorption bands doped with ZnS and excitation bands of luminescence compositions, as well as an increase in the intensity of narrow-band luminescence of Eu3+ ions while reducing the intensity of a wide band of recombination luminescence of doped ZnS. A decrease in the intensity of the ZnS recombination luminescence band with an increase in the concentration of Eu3+ >1.0∙10-3 mol/L ions is also associated with the formation of a layer of complex europium compounds on the particle surface that prevent the passage of exciting radiation to the particle core.